Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v3.24.1.1.u2
Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Current Assets    
Cash and cash equivalents $ 1,195 $ 2,815
Trading marketable securities 6,414 7,611
Prepaid expenses and other current assets 579 554
Total Current Assets 8,188 10,980
Operating lease right-of-use assets 124 21
Intangible asset 2,039 2,039
Other assets 3 3
TOTAL ASSETS 10,354 13,043
Current Liabilities    
Accounts payable and accrued liabilities 607 1,238
Due to related parties 83 30
Operating lease liabilities - current portion 31 23
Total Current Liabilities 721 1,291
Operating lease liabilities 96 0
TOTAL LIABILITIES 817 1,291
STOCKHOLDERS' EQUITY    
Preferred Stock, par value $0.001, 416,667 shares authorized, 0 shares issued and outstanding as of March 31, 2024 and December 31, 2023 0 0
Common Stock, par value $0.001, 50,000,000 shares authorized, as of March 31, 2024 and December 31, 2023 3,227,700 and 3,188,959 shares issued and outstanding as of March 31, 2024 and December 31, 2023 3 3
Additional paid-in capital 52,530 52,262
Accumulated deficit (42,793) (40,310)
Accumulated other comprehensive loss (203) (203)
TOTAL STOCKHOLDERS' EQUITY 9,537 11,752
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 10,354 $ 13,043